mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.009 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.01 |